Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

602
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
602
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

927
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
927
Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

991
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
991
Restless Leg Syndrome and Night Terrors01:27

Restless Leg Syndrome and Night Terrors

529
Restless Leg Syndrome (RLS), also known as Willis-Ekbom disease, is a neurological disorder characterized by an uncontrollable urge to move the legs due to uncomfortable sensations. These sensations typically occur during periods of rest or inactivity, particularly when lying down or sitting, and can severely disrupt sleep.
The exact cause of RLS is not fully understood, but it is believed to involve dopamine, a neurotransmitter that helps regulate muscle movement. Imbalances in dopamine levels...
529
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

316
Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
316
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

236
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
236

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The NDT and MARKUS@HOMe Partnership.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2026
Same author

[Prevention and screening in nephrology].

Innere Medizin (Heidelberg, Germany)·2026
Same author

Pelacarsen and lipoprotein(a) apheresis in secondary prevention: the Lp(a)FRONTIERS APHERESIS trial.

European heart journal·2026
Same author

Circulating trimethylamine N-oxide and cardiovascular, cerebral, and renal diseases including mortality: Umbrella review of published systematic reviews and meta-analyses.

Nutrition, metabolism, and cardiovascular diseases : NMCD·2025
Same author

ApoM and Major Adverse Cardiovascular Events in Chronic Kidney Disease: A Prospective Cohort Study.

Arteriosclerosis, thrombosis, and vascular biology·2025
Same author

Association of Homocysteine, S-Adenosylhomocysteine and S-Adenosylmethionine with Cardiovascular Events in Chronic Kidney Disease.

Nutrients·2025

Related Experiment Video

Updated: Jan 27, 2026

Conscious and Non-conscious Representations of Emotional Faces in Asperger's Syndrome
08:31

Conscious and Non-conscious Representations of Emotional Faces in Asperger's Syndrome

Published on: July 31, 2016

14.5K

[The Cardiorenal Syndrome].

Vincent Brandenburg, Gunnar H Heine

    Deutsche Medizinische Wochenschrift (1946)
    |March 15, 2019
    PubMed
    Summary

    Chronic cardiorenal syndrome, a condition where heart and kidney disease coexist, presents a high risk for cardiovascular events. Management focuses on fluid control and renin-angiotensin-aldosterone system inhibition, improving long-term outcomes.

    Area of Science:

    • Cardiology
    • Nephrology
    • Internal Medicine

    Background:

    • Chronic cardiorenal syndrome involves the dangerous coexistence of chronic heart disease and chronic kidney disease.
    • This condition significantly elevates the risk of cardiovascular events and mortality in affected patients.
    • Evidence-based treatment recommendations for this complex syndrome are currently limited.

    Purpose of the Study:

    • To review the current understanding and management strategies for chronic cardiorenal syndrome.
    • To highlight the importance of interdisciplinary care in optimizing patient outcomes.
    • To discuss the role of specific pharmacotherapies in managing fluid balance and organ function.

    Main Methods:

    • Review of existing literature on cardiorenal syndrome.

    More Related Videos

    Portable Thermographic Screening for Detection of Acute Wallenberg's Syndrome
    05:12

    Portable Thermographic Screening for Detection of Acute Wallenberg's Syndrome

    Published on: September 19, 2019

    6.9K
    Author Spotlight: A Battery of Highly Reproducible Behavioral Tests to Validate an Angelman Syndrome Murine Model
    11:05

    Author Spotlight: A Battery of Highly Reproducible Behavioral Tests to Validate an Angelman Syndrome Murine Model

    Published on: October 20, 2023

    5.7K

    Related Experiment Videos

    Last Updated: Jan 27, 2026

    Conscious and Non-conscious Representations of Emotional Faces in Asperger's Syndrome
    08:31

    Conscious and Non-conscious Representations of Emotional Faces in Asperger's Syndrome

    Published on: July 31, 2016

    14.5K
    Portable Thermographic Screening for Detection of Acute Wallenberg's Syndrome
    05:12

    Portable Thermographic Screening for Detection of Acute Wallenberg's Syndrome

    Published on: September 19, 2019

    6.9K
    Author Spotlight: A Battery of Highly Reproducible Behavioral Tests to Validate an Angelman Syndrome Murine Model
    11:05

    Author Spotlight: A Battery of Highly Reproducible Behavioral Tests to Validate an Angelman Syndrome Murine Model

    Published on: October 20, 2023

    5.7K
  • Analysis of therapeutic approaches focusing on fluid metabolism and organ stabilization.
  • Discussion of the impact of renin-angiotensin-aldosterone system inhibitors and diuretics.

    • Main Results:

    • Fluid metabolism control and stabilization of renal and cardiac function are key therapeutic goals.
    • Inhibition of the renin-angiotensin-aldosterone system (RAAS) and diuretics, despite potential short-term renal function decrease (pseudo-worsening), are associated with long-term outcome improvement.
    • Interdisciplinary collaboration between nephrologists and cardiologists is crucial.

    Conclusions:

    • Effective management of chronic cardiorenal syndrome requires a coordinated, interdisciplinary approach.
    • Pharmacological interventions targeting the RAAS and fluid balance are essential for improving long-term prognosis.
    • Optimizing patient care necessitates minimizing treatment-related side effects while maximizing therapeutic benefits.